Literature DB >> 26445249

[Thromboangiitis obliterans (Buerger's disease): update 2015].

Peter Klein-Weigel1, Theresa Sophie Volz1, Jutta Richter2.   

Abstract

Thromboangiitis obliterans (Buerger's disease) is a vasculitis with undulating clinical course multisegmentarily affecting small and medium-sized arteries and veins. The disease is closely linked to tobacco-use. Increasing knowledge of autoimmunologic mechanisms in the complex pathophyiology of the disease let to the formulation of an autoimmunity-hypothesis now serving as a new paradigma. New treatment options comprise progenitor-cell-therapy, immunoadsorption, use of sendothelin-receptor-blocking agent Bosentan, and prescriptions of antiphosphodiesterase-V-inhibitors. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26445249     DOI: 10.1055/s-0041-106246

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  [Necrosis with mummification of the foot in a 33-year-old man with anxiety disorder].

Authors:  D Zajonz; N von der Höh; M Moche; T Lingscheidt; C Josten; C-E Heyde; U J A Spiegl
Journal:  Chirurg       Date:  2017-08       Impact factor: 0.955

2.  Therapeutic Effect and Mechanism of Si-Miao-Yong-An-Tang on Thromboangiitis Obliterans Based on the Urine Metabolomics Approach.

Authors:  Hui-Yu Li; Hui Sun; Ai-Hua Zhang; Lu-Wen He; Shi Qiu; Jun-Ru Xue; Fangfang Wu; Xi-Jun Wang
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.